Evaluation of experimental effect of hemovigilance under different environmental conditions
-
摘要: 目的 通过持续开展血液安全监测，分析存在的问题及原因，为医疗机构提供整改建议，以提高血液安全和合理用血水平。方法 通过对多家医院进行血液安全监测检查，发现了一些共性问题，包括设施和环境条件、人员配置、实验室设备、试剂和耗材、检验前后过程的质量控制等方面。针对这些问题，提出了具体的整改建议。结果 通过对问题进行整改和完善，各医疗机构在血液安全监测方面取得了显著进步，血液安全和合理用血水平得到了提高。在临床用血管理、自体输血、输血病历评价等方面均取得了较好的成果。结论 持续开展血液安全监测有助于提高医疗机构血液安全水平，提升合理用血水平，保障患者生命安全，提高医疗质量。这对于推动我国血液安全监测工作的发展具有重要意义。Abstract: Objective To provide corrective suggestions for medical institutions by continuously carrying out hemovigilance (HV), analyzing existing issues, and identifying their causes, and improve blood safety and rational blood use.Methods This study conducted HV inspections in multiple hospitals, identifying common issues including facility and environmental conditions, personnel allocation, laboratory equipment, reagents and consumables, and quality control in pre-and post-analytical processes. Specific corrective suggestions were proposed for these issues.Results After addressing and optimizing these issues, medical institutions achieved significant progress in HV, improving blood safety and rational blood use levels. Better results were achieved in clinical blood use management, autologous transfusion, and transfusion medical record evaluations.Conclusion This study indicated that continuous HV implementation could help enhance blood safety levels in medical institutions, promote rational blood use, safeguard patient safety, and improve medical quality. This might be significant implications for advancing HV work in China.
-
Key words:
- hemovigilance /
- blood infectious diseases /
- blood reactions /
- rational use of blood
-
-
表 1 设施和环境条件的统计情况
分 设施/环境条件 实验组平均评分 对照组平均评分 储血设备温度控制 4.5 4.0 环境卫生清洁消毒 4.8 4.2 业务用房布局 4.4 3.7 关键设备维护 4.6 4.0 血袋回收处理 4.3 3.9 
下载: 导出CSV
表 2 2组相关系数矩阵
类型 实验组 对照组 X1 X2 X3 X4 Y X1 X2 X3 X4 Y X1 1.000 0 0.654 5 0.314 1 0.278 7 0.788 4 1.00 0.71 0.25 0.09 0.76 X2 0.654 5 1.000 0 0.217 9 0.232 6 0.745 8 0.71 1.00 0.42 0.06 0.69 X3 0.314 1 0.217 9 1.000 0 0.542 6 0.364 7 0.25 0.42 1.00 0.19 0.31 X4 0.278 7 0.232 6 0.542 6 1.000 0 0.266 4 0.09 0.06 0.19 1.00 0.22 Y 0.788 4 0.745 8 0.364 7 0.266 4 1.000 0 0.76 0.69 0.31 0.22 1.00
下载: 导出CSV
表 3 2组方差分析
组别 df SS 均方 F P 实验组 回归 4 1.078 6 0.269 6 27.126 8 0.000 2 残差 20 0.502 7 0.025 1 总和 24 1.581 3 对照组 回归 15 34.63 34.63 6.23 0.030 残差 15 58.44 3.90 总和 19 105.06
下载: 导出CSV
-
[1] 陈萍, 陈妍, 颜鑫, 等. 2016-2021年济南地区无偿献血者HIV感染状况及特征分析[J]. 临床血液学杂志, 2023, 36(6): 440-444. https://lcxy.whuhzzs.com/article/doi/10.13201/j.issn.1004-2806.2023.06.013
[2] 刘淼. 戊型肝炎病毒与血液安全的研究进展[J]. 中国输血杂志, 2023, 36(4): 359-364.
[3] 陈莉, 贾桂丛, 戚海, 等. 某省血液安全监测平台构建研究[J]. 中国卫生质量管理, 2018, 25(6): 1-4, 8.
[4] 贾东晨, 于鹏丽, 吴舟一, 等. 血液制品病毒安全性药学审评考虑[J]. 中国新药杂志, 2023, 32(2): 168-173. doi: 10.3969/j.issn.1003-3734.2023.02.012
[5] 黄霞, 杨俊鸿, 何涛. 血液安全监测选择与未来[J]. 临床输血与检验, 2023, 25(1): 10-15.
[6] 袁君, 李娜, 王伟, 等. 输血前患者传染病4项检测阳性结果的准确性研究[J]. 临床血液学杂志, 2023, 36(6): 436-439, 444. https://lcxy.whuhzzs.com/article/doi/10.13201/j.issn.1004-2806.2023.06.012
[7] 谢东甫, 黄霞, 杨俊鸿, 等. 国内外血液安全监测报告若干数据指标的比较与分析[J]. 临床输血与检验, 2023, 25(1): 16-20.
[8] 王亚玲, 余韵, 文爱清, 等. 中英血液安全及输血管理实践的比较(七)--临床输血全国比较审核[J]. 中国输血杂志, 2022, 35(3): 349-356.
[9] Pitman JP, Payrat JM, Park MS, et al. Longitudinal analysis of annual national hemovigilance data to assess pathogen reduced platelet transfusion trends during conversion to routine universal clinical use and 7-day storage[J]. Transfusion, 2023, 63(4): 711-723.
[10] Vuk T, Politis C, Laspina S, et al. Thirty years of hemovigilance-Achievements and future perspectives[J]. Transfus Clin Biol, 2023, 30(1): 166-172.
[11] 程志祥, 任林, 曹红荣, 等. 基于《血液安全监测指南》开展临床输血不良事件监测的探索[J]. 临床输血与检验, 2023, 25(1): 48-55.
[12] 赵广超, 毛平平, 齐清, 等. 献血者高血糖水平影响血液工作安全性的研究进展[J]. 临床血液学杂志, 2023, 36(8): 603-606. https://lcxy.whuhzzs.com/article/doi/10.13201/j.issn.1004-2806.2023.08.016
[13] 陈莉, 黄霞, 戚海, 等. 通过血液安全监测平台确认并预警献血后1型糖尿病1例[J]. 中国输血杂志, 2020, 33(10): 1107-1109.
[14] 吴晓晋, 陈宏伟, 黄志翔, 等. 两种血液核酸筛查系统的核酸筛查能力比较研究[J]. 中国医学装备, 2022, 19(9): 26-30.
[15] 陈明军, 张燕, 吕永磊. 梅毒化学发光与酶联免疫试剂的性能对比分析[J]. 临床血液学杂志, 2022, 35(2): 126-129. https://lcxy.whuhzzs.com/article/doi/10.13201/j.issn.1004-2806.2022.02.010
[16] 王韵, 汪峰, 费静娴, 等. 采供血机构ALT初筛检测质量保证的探讨[J]. 临床血液学杂志, 2022, 35(12): 884-887. https://lcxy.whuhzzs.com/article/doi/10.13201/j.issn.1004-2806.2022.12.011
[17] 王波, 庄广萍, 滕亚莉. 基于"WHO血液安全行动框架"管理献血点的效果分析[J]. 中国卫生标准管理, 2023, 14(3): 185-188.
[18] 孙亚纯, 王雷萍, 邓桂花, 等. 某三甲综合性医院2016-2022年输血不良事件回顾性分析[J]. 中国输血杂志, 2023, 36(7): 601-604.
[19] 李楠, 李归宁, 甘蕾, 等. 单中心输血前患者意外抗体筛查结果分析[J]. 临床血液学杂志, 2023, 36(4): 230-234. https://lcxy.whuhzzs.com/article/doi/10.13201/j.issn.1004-2806.2023.04.002
[20] Dhiman Y, Raturi M, Kala M, et al. Significance of mandating a dedicated hemovigilance nurse and objectification of 'imputability' levels. Experience from a hospital-based blood centre in India[J]. Transfus Clin Biol, 2023, 30(1): 96-102.
[21] Lea Nicole C, Karen G, Chantay J, et al. Transfusion-associated adverse events: a case report of nurse hemovigilance and recognition of respiratory distress[J]. J Infus Nurs, 2022, 45(5): 264-269.
[22] Behnammoghadam M, Fazelniya Z, Bayat AH, et al. Effect of hemovigilance education on nursing students' knowledge: the application of a conceptual map[J]. Front Nurs, 2022, 9(3): 295-301.
-